Literature DB >> 2339094

Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling.

G E Parry1, A L Bunge, G D Silcox, L K Pershing, D W Pershing.   

Abstract

The percutaneous absorption of benzoic acid across human skin in vitro was experimentally and mathematically modeled. Skin partition coefficients were measured over a range of benzoic acid concentrations in both saline and distilled water. The permeation of benzoic acid was measured across isolated stratum corneum, stratum corneum and epidermis, and split-thickness skin. These experiments demonstrated that the stratum corneum was the rate-limiting barrier and that the flux is proportional to the concentration of the undissociated species. The permeation data were analyzed with a comprehensive non-steady-state mathematical model of diffusion across skin. Two adjustable parameters, the effective skin thickness and diffusivity, were fit to the permeation data by nonlinear regression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339094     DOI: 10.1023/a:1015861709758

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  The measurement of the stratum corneum reservoir: a simple method to predict the influence of vehicles on in vivo percutaneous absorption.

Authors:  D Dupuis; A Rougier; R Roguet; C Lotte
Journal:  Br J Dermatol       Date:  1986-08       Impact factor: 9.302

2.  Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids.

Authors:  R J Scheuplein; L W Ross
Journal:  J Invest Dermatol       Date:  1974-04       Impact factor: 8.551

3.  Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.

Authors:  R J Scheuplein
Journal:  J Invest Dermatol       Date:  1965-11       Impact factor: 8.551

Review 4.  Epidermal lipids, membranes, and keratinization.

Authors:  P M Elias
Journal:  Int J Dermatol       Date:  1981 Jan-Feb       Impact factor: 2.736

5.  Percutaneous absorption on the relevance of in vitro data.

Authors:  T J Franz
Journal:  J Invest Dermatol       Date:  1975-03       Impact factor: 8.551

6.  Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin.

Authors:  R L Bronaugh; T J Franz
Journal:  Br J Dermatol       Date:  1986-07       Impact factor: 9.302

7.  Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate II: Parameter determinations.

Authors:  C D Yu; J L Fox; N F Ho; W I Higuchi
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

  7 in total
  6 in total

1.  Does epidermal turnover reduce percutaneous penetration?

Authors:  M B Reddy; R H Guy; A L Bunge
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  A new method for estimating dermal absorption from chemical exposure. 1. General approach.

Authors:  R L Cleek; A L Bunge
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

3.  Disparity of in vitro and in vivo oleic acid-enhanced beta-estradiol percutaneous absorption across human skin.

Authors:  L K Pershing; G E Parry; L D Lambert
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

4.  Development of a Two-Dimensional Model for Predicting Transdermal Permeation with the Follicular Pathway: Demonstration with a Caffeine Study.

Authors:  Panayiotis Kattou; Guoping Lian; Stephen Glavin; Ian Sorrell; Tao Chen
Journal:  Pharm Res       Date:  2017-06-28       Impact factor: 4.200

5.  Lanolin-Based Synthetic Membranes for Transdermal Permeation and Penetration Drug Delivery Assays.

Authors:  Cristina Alonso; Ilaria Collini; Meritxell Martí; Clara Barba; Luisa Coderch
Journal:  Membranes (Basel)       Date:  2021-06-15

6.  Assessment of Finite and Infinite Dose In Vitro Experiments in Transdermal Drug Delivery.

Authors:  Luisa Coderch; Ilaria Collini; Victor Carrer; Clara Barba; Cristina Alonso
Journal:  Pharmaceutics       Date:  2021-03-10       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.